# An Efficacy and Safety Study of Clemizole HCl in Patients With Lennox-Gastaut Syndrome

> **NCT05066217** · PHASE3 · RECRUITING · sponsor: **Epygenix** · enrollment: 260 (estimated)

## Conditions studied

- Lennox Gastaut Syndrome

## Interventions

- **DRUG:** Clemizole HCl
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT05066217
- **Lead sponsor:** Epygenix
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-04-09
- **Primary completion:** 2026-11-01
- **Final completion:** 2029-11-01
- **Target enrollment:** 260 (ESTIMATED)
- **Last updated:** 2026-04-15

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05066217

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05066217, "An Efficacy and Safety Study of Clemizole HCl in Patients With Lennox-Gastaut Syndrome". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT05066217. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*